| Dr Noel L Snowberger, MD | |
|
12200 Park Central Dr, Suite 403, Dallas, TX 75251-2100 | |
| (972) 239-2400 | |
| (972) 239-2403 |
| Full Name | Dr Noel L Snowberger |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 24 Years |
| Location | 12200 Park Central Dr, Dallas, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396788162 | NPI | - | NPPES |
| 182899801 | Medicaid | TX | |
| 8A7897 | Other | TX | BCBSTX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | M4555 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical City Dallas Hospital | Dallas, TX | Hospital |
| Baylor University Medical Center | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Digestive Disease Consultants Pllc | 3375531379 | 544 |
News Archive
The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Average healthcare costs for U.S. employers increased 7.3 percent in 2009, according to study published today by Thomson Reuters. The year-over-year increase topped the 2008 rate of 6.1 percent and occurred in a year when the U.S. inflation rate was negative.
Firefly BioWorks, Inc., a developer of next-generation multiplexed assays for biomarker detection, announced today the awarding of a $500K Grant from the Massachusetts Life Sciences Center.
A simple toolkit of checklists, education materials and quality and performance reporting improved the quality of care but not outcomes in hospitals in the south Indian state of Kerala and may have the potential to improve outcomes of heart attacks and other major cardiovascular disease events in other settings, according to a new Northwestern Medicine study published in the Journal of the American Medical Association.
› Verified 3 days ago
| Entity Name | Digestive Health Associates Of Texas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831158310 PECOS PAC ID: 2769372150 Enrollment ID: O20040318001014 |
News Archive
The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Average healthcare costs for U.S. employers increased 7.3 percent in 2009, according to study published today by Thomson Reuters. The year-over-year increase topped the 2008 rate of 6.1 percent and occurred in a year when the U.S. inflation rate was negative.
Firefly BioWorks, Inc., a developer of next-generation multiplexed assays for biomarker detection, announced today the awarding of a $500K Grant from the Massachusetts Life Sciences Center.
A simple toolkit of checklists, education materials and quality and performance reporting improved the quality of care but not outcomes in hospitals in the south Indian state of Kerala and may have the potential to improve outcomes of heart attacks and other major cardiovascular disease events in other settings, according to a new Northwestern Medicine study published in the Journal of the American Medical Association.
› Verified 3 days ago
| Entity Name | Texas Digestive Disease Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053397331 PECOS PAC ID: 3375531379 Enrollment ID: O20040505001844 |
News Archive
The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Average healthcare costs for U.S. employers increased 7.3 percent in 2009, according to study published today by Thomson Reuters. The year-over-year increase topped the 2008 rate of 6.1 percent and occurred in a year when the U.S. inflation rate was negative.
Firefly BioWorks, Inc., a developer of next-generation multiplexed assays for biomarker detection, announced today the awarding of a $500K Grant from the Massachusetts Life Sciences Center.
A simple toolkit of checklists, education materials and quality and performance reporting improved the quality of care but not outcomes in hospitals in the south Indian state of Kerala and may have the potential to improve outcomes of heart attacks and other major cardiovascular disease events in other settings, according to a new Northwestern Medicine study published in the Journal of the American Medical Association.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Noel L Snowberger, MD 7610 N Stemmons Fwy Ste 600, Dallas, TX 75247-4228 Ph: (214) 689-5960 | Dr Noel L Snowberger, MD 12200 Park Central Dr, Suite 403, Dallas, TX 75251-2100 Ph: (972) 239-2400 |
News Archive
The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
Average healthcare costs for U.S. employers increased 7.3 percent in 2009, according to study published today by Thomson Reuters. The year-over-year increase topped the 2008 rate of 6.1 percent and occurred in a year when the U.S. inflation rate was negative.
Firefly BioWorks, Inc., a developer of next-generation multiplexed assays for biomarker detection, announced today the awarding of a $500K Grant from the Massachusetts Life Sciences Center.
A simple toolkit of checklists, education materials and quality and performance reporting improved the quality of care but not outcomes in hospitals in the south Indian state of Kerala and may have the potential to improve outcomes of heart attacks and other major cardiovascular disease events in other settings, according to a new Northwestern Medicine study published in the Journal of the American Medical Association.
› Verified 3 days ago
Uma B.r.k Pakkivenkata, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 215, Dallas, TX 75231 Phone: 214-396-4950 Fax: 877-423-5360 | |
Dr. Ariel Marcelo Modrykamien, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 960, Dallas, TX 75246 Phone: 402-972-6078 | |
Benjamin Seth Martinez, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3111 Fax: 214-648-5461 | |
Vijaya Mummadi, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 225, Dallas, TX 75231 Phone: 469-646-8880 Fax: 469-646-8884 | |
Dr. Ting-yi Chen, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2800 Fax: 214-645-2808 | |
William Cook Langmade, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1441 N Beckley Ave, Dallas, TX 75203 Phone: 214-947-2306 | |
Dr. Janame J Kottey, MBBS Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 13154 Coit Rd Ste 100, Dallas, TX 75240 Phone: 214-358-2300 Fax: 214-579-6989 |